Secondary iron overload induces chronic pancreatitis and ferroptosis of acinar cells in mice.
OA: gold
CC-BY-NC-ND-4.0
Abstract
Disruption of iron homeostasis is associated with multiple diseases. It has been found that patients with genetic iron overload develop massive iron deposition in the pancreas. However, few studies have focused on the effect of secondary iron overload on the pancreas. The objective of the present study was to investigate the pathogenic consequences of secondary iron overload in mice. An iron overload mouse model was constructed by intraperitoneal injection of 120 mg/kg body weight of iron dextran every other week for 12 weeks. Iron deposition, immunocyte infiltration, fibrosis, oxidative stress and ferroptosis were assessed using Prussian blue staining, immunohistochemical analysis, Masson staining, Sirius red staining, RT‑qPCR analysis and western blot analysis. It was found that iron‑overloaded mice showed pancreatic iron overload, together with elevated gene expression of the iron storage factor ferritin H, and decreased expression of the iron transportation mediator divalent metal transporter 1, ferroportin 1 and transferrin receptor. Iron‑overloaded mice developed mild pancreatitis with increased serum amylase and lipase activities, as well as elevated gene expression levels of pro‑inflammatory cytokines, including interleukin (IL)‑1β, IL‑6 and inducible nitric oxide synthase. Acinar atrophy, massive immunocyte infiltration and pancreatic fibrosis were noted in the iron‑overloaded mice. As an underlying mechanism, iron‑overloaded mice showed increased pancreatic oxidative stress, with an elevated malondialdehyde level, and decreased SOD and glutathione peroxidase activity. Furthermore, iron overload led to ferroptosis with promoted expression of cytochrome c oxidase subunit II, and decreased transcripts of glutathione peroxidase 4 and solute carrier family 7 member 11. These results provided evidence that multiple intraperitoneal injections of iron dextran in mice lead to iron overload‑induced chronic pancreatitis, which suggested that secondary iron overload is a risk factor for pancreatitis and highlights the importance of iron in maintaining the normal functions of the pancreas.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
References (62)
- Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition. via crossref
- Diagnosis and Management of Chronic Pancreatitis: A Review. via crossref
- United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). via crossref
- doi:10.1016/j.cell.2010.06.028 via crossref
- doi:10.1152/physrev.00008.2013 via crossref
- doi:10.1080/10408398.2017.1376616 via crossref
- doi:10.1111/j.1467-789x.2009.00638.x via crossref
- doi:10.1186/s40168-021-01052-7 via crossref
- doi:10.1016/j.molmed.2019.05.012 via crossref
- doi:10.1056/nejmra1004967 via crossref
- doi:10.1016/s2213-8587(13)70174-8 via crossref
- doi:10.1038/nrdp.2018.16 via crossref
- doi:10.1007/s12011-019-01867-4 via crossref
- doi:10.1016/j.metabol.2009.08.006 via crossref
- doi:10.1002/ajh.21541 via crossref
- doi:10.1111/j.1365-2141.2009.07793.x via crossref
- doi:10.1002/ajh.23543 via crossref
- doi:10.1038/s41575-019-0158-2 via crossref
- doi:10.1016/j.ajpath.2017.08.017 via crossref
- doi:10.1016/j.cca.2020.10.013 via crossref
- doi:10.1002/path.4822 via crossref
- doi:10.3892/ijmm.2021.4893 via crossref
- doi:10.1016/j.jhep.2021.05.005 via crossref
- doi:10.1182/blood-2011-01-258467 via crossref
- doi:10.1080/00365521.2020.1712471 via crossref
- doi:10.1006/meth.2001.1262 via crossref
- doi:10.3390/foods10081787 via crossref
- doi:10.1002/hep.32270 via crossref
- doi:10.1016/j.cmet.2009.03.006 via crossref
- doi:10.1089/ars.2020.8168 via crossref
- doi:10.1002/jcsm.12897 via crossref
- doi:10.1016/s0140-6736(20)31318-0 via crossref
- doi:10.1038/nrdp.2017.60 via crossref
- doi:10.4292/wjgpt.v8.i1.10 via crossref
- doi:10.1007/s12026-014-8504-5 via crossref
- doi:10.1038/nri3399 via crossref
- doi:10.1053/j.gastro.2016.07.043 via crossref
- doi:10.1196/annals.1326.018 via crossref
- doi:10.1038/s41467-020-20154-8 via crossref
- doi:10.18632/oncotarget.7776 via crossref
- doi:10.1038/ajg.2017.218 via crossref
- doi:10.18632/oncotarget.4338 via crossref
- doi:10.1016/j.cub.2020.09.068 via crossref
- doi:10.1016/j.cell.2012.03.042 via crossref
- doi:10.1038/cdd.2015.158 via crossref
- doi:10.1016/j.ijbiomac.2020.02.034 via crossref
- doi:10.1155/2014/360438 via crossref
- doi:10.3390/antiox9111132 via crossref
- doi:10.1016/j.ab.2016.10.021 via crossref
- doi:10.1016/j.cbpc.2005.07.009 via crossref
- doi:10.1016/j.jep.2011.02.029 via crossref
- doi:10.1016/s1535-6108(03)00050-3 via crossref
- doi:10.1002/pmic.201800311 via crossref
- doi:10.1016/j.ijbiomac.2022.09.055 via crossref
- doi:10.3389/fnmol.2018.00486 via crossref
- doi:10.1016/j.chembiol.2020.03.016 via crossref
- doi:10.1038/s41419-020-2334-2 via crossref
- doi:10.1016/j.freeradbiomed.2021.07.009 via crossref
- doi:10.1371/journal.pcbi.1006060 via crossref
- doi:10.1007/s10620-020-06225-2 via crossref
- doi:10.1039/c7mt00116a via crossref
- doi:10.1038/nri3863 via crossref
Source provenance
- crossref
- last seen: 2026-08-12T06:42:36.601229+00:00
- europepmc
- last seen: 2026-08-16T09:21:09.727480+00:00
- unpaywall
- last seen: 2026-08-12T06:43:03.944938+00:00
License: CC-BY-NC-ND-4.0